TEE
OPTN

Tibra Equities Europe’s OptiNose OPTN Stock Holding History

Tibra Equities Europe’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,820
Closed -$318K – 148
2021
Q2 		$318K Buy
+6,820
New +$348K 0.1% 153

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Tibra Equities Europe's OPTN Position: Q3 2021 in Review

Tibra Equities Europe sold out of OptiNose (OPTN) in Q3 2021, closing a stake of 6,820 shares — an estimated $318K sold.

Tibra Equities Europe first reported a position in OPTN in Q2 2021 and held it in 1 quarter. The position peaked at $318K in Q2 2021. 49 funds tracked by Wall St. Rank hold OPTN as of Q3 2021.

  • Tibra Equities Europe reported no remaining OptiNose position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 6,820 OptiNose shares in Q3 2021, an estimated $318K.
  • Tibra Equities Europe first reported a position in OptiNose in Q2 2021 and held it in 1 quarter.
  • Tibra Equities Europe's OptiNose position peaked at $318K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held OptiNose as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.